FDA Drug recall D-0180-2023
Epinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch as (a)100 G
- FDA Drug
- Class I
- terminated
- Published 2023-02-01
On 2023-02-01 the FDA classified a Class I recall of Epinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch as (a)100 G by Spectrum Laboratory Products, citing discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0180-2023 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2022-12-19 |
| Published | 2023-02-01 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Spectrum Laboratory Products |
| Distribution | US |
Product
Epinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch as (a)100 G; (b)1 G, (c) 25 G, (d) 5 G; Rx only. Repackaged by Spectrum Chemical Mfg. Corp. Gardena, CA 90248; New Brunswick, NJ 08901.
Reason
Discoloration: Product complaints of the repackaged Epinephrine API being discolored which could result in less effective product
Identifiers
| code_info | Lot # (a) (b) (c) (d) lot 2KL0353, EXP 30-Sep-2023; 2KF0151, EXP 31-Mar-2023 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0180-2023%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.